Clinical Trials Directory

Trials / Completed

CompletedNCT01340157

Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions

Randomized, Open Study to Assess the Impact of Two Different Types of Food on the Relative Bioavailability of Fexinidazole Tablets After Single Oral Dose in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Drugs for Neglected Diseases · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The present study is designed to assess the impact of concomitant food intake on the relative bioavailability of a single oral fexinidazole tablet administration.

Conditions

Interventions

TypeNameDescription
DRUGFexinidazoleSingle oral dose of 1200mg fexinidazole consisting of 2 tablets dosed at 600mg per tablet.

Timeline

Start date
2011-02-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2011-04-22
Last updated
2017-03-31

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01340157. Inclusion in this directory is not an endorsement.

Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions (NCT01340157) · Clinical Trials Directory